| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/30/2023 | 68.35% | Needham | → $15 | Reiterates | Buy → Buy |
| 08/24/2023 | 68.35% | Needham | → $15 | Reiterates | Buy → Buy |
| 08/24/2023 | 79.57% | Canaccord Genuity | → $16 | Reiterates | Buy → Buy |
| 07/13/2023 | 34.68% | Baird | → $12 | Initiates Coverage On | → Neutral |
| 06/23/2023 | 68.35% | Needham | → $15 | Reiterates | Buy → Buy |
| 06/22/2023 | 68.35% | Needham | → $15 | Reiterates | Buy → Buy |
| 05/25/2023 | 34.68% | Lake Street | $11 → $12 | Maintains | Buy |
| 05/25/2023 | 68.35% | Needham | → $15 | Reiterates | Buy → Buy |
| 05/25/2023 | 79.57% | Canaccord Genuity | → $16 | Reiterates | Buy → Buy |
| 04/10/2023 | 68.35% | Needham | → $15 | Reiterates | → Buy |
| 03/03/2023 | 79.57% | Canaccord Genuity | $15 → $16 | Maintains | Buy |
| 03/02/2023 | 68.35% | Needham | → $15 | Reiterates | → Buy |
| 01/31/2023 | 23.46% | Lake Street | → $11 | Initiates Coverage On | → Buy |
| 12/09/2022 | 68.35% | Canaccord Genuity | $20 → $15 | Maintains | Buy |
| 10/21/2022 | 1.01% | Goldman Sachs | → $9 | Initiates Coverage On | → Neutral |
| 08/25/2022 | 68.35% | Needham | $24 → $15 | Maintains | Buy |
| 10/11/2021 | 169.36% | Needham | → $24 | Upgrades | Hold → Buy |
| 10/01/2021 | 102.02% | Morgan Stanley | → $18 | Upgrades | Underweight → Equal-Weight |
| 09/30/2021 | 169.36% | Craig-Hallum | → $24 | Initiates Coverage On | → Buy |
| 04/13/2021 | 124.47% | Canaccord Genuity | $19 → $20 | Maintains | Buy |
| 04/08/2021 | 124.47% | Berenberg | → $20 | Initiates Coverage On | → Buy |
| 06/16/2020 | 62.74% | Northland Capital Markets | → $14.5 | Initiates Coverage On | → Market Perform |
| 06/04/2020 | 113.24% | Canaccord Genuity | $15 → $19 | Maintains | Buy |
| 06/04/2020 | 23.46% | Morgan Stanley | $8.5 → $11 | Maintains | Underweight |
| 05/14/2020 | 23.46% | Jefferies | → $11 | Downgrades | Buy → Hold |
| 04/14/2020 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 03/16/2020 | -4.6% | Morgan Stanley | $17 → $8.5 | Maintains | Equal-Weight |
| 03/13/2020 | — | Needham | Downgrades | Buy → Hold | |
| 01/15/2020 | — | First Analysis | Initiates Coverage On | → Outperform | |
| 05/31/2019 | 79.57% | Morgan Stanley | $22 → $16 | Maintains | Equal-Weight |
| 05/31/2019 | 102.02% | Canaccord Genuity | $28 → $18 | Maintains | Buy |
| 05/31/2019 | — | Needham | Downgrades | Strong Buy → Buy | |
| 03/19/2019 | — | Canaccord Genuity | Upgrades | Hold → Buy | |
| 02/01/2019 | — | Goldman Sachs | Reinstates | → Sell | |
| 10/23/2018 | 169.36% | Morgan Stanley | $26 → $24 | Maintains | Equal-Weight |
| 08/31/2018 | 191.81% | Morgan Stanley | $24 → $26 | Maintains | Equal-Weight |
| 08/31/2018 | 214.25% | Canaccord Genuity | $26 → $28 | Maintains | Hold |
What is the target price for Zuora (ZUO)?
The latest price target for Zuora (NYSE: ZUO) was reported by Needham on August 30, 2023. The analyst firm set a price target for $15.00 expecting ZUO to rise to within 12 months (a possible 68.35% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zuora (ZUO)?
The latest analyst rating for Zuora (NYSE: ZUO) was provided by Needham, and Zuora reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Zuora (ZUO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zuora, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zuora was filed on August 30, 2023 so you should expect the next rating to be made available sometime around August 30, 2024.
Is the Analyst Rating Zuora (ZUO) correct?
While ratings are subjective and will change, the latest Zuora (ZUO) rating was a reiterated with a price target of $0.00 to $15.00. The current price Zuora (ZUO) is trading at is $8.91, which is within the analyst's predicted range.